Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oracea for Papulopustular Rosacea
NCT01308619Phase 4Completed
- Sponsor
- Galderma
- Start
- Apr 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in papulopustular rosacea, sponsored by Galderma. Started Apr 2011; status: completed.
02
Drugs
doxycycline
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT01308619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01308619.